275 related articles for article (PubMed ID: 32882218)
1. CSN6 aggravates Ang II-induced cardiomyocyte hypertrophy via inhibiting SIRT2.
Mei ZL; Wang HB; Hu YH; Xiong L
Exp Cell Res; 2020 Nov; 396(1):112245. PubMed ID: 32882218
[TBL] [Abstract][Full Text] [Related]
2. PHD Finger Protein 19 Promotes Cardiac Hypertrophy via Epigenetically Regulating SIRT2.
Gu W; Cheng Y; Wang S; Sun T; Li Z
Cardiovasc Toxicol; 2021 Jun; 21(6):451-461. PubMed ID: 33611744
[TBL] [Abstract][Full Text] [Related]
3. CSN6 inhibition suppresses pancreatic adenocarcinoma metastasis via destabilizing the c-Fos protein.
Ma F; Wang H; Liu K; Wang Z; Chen S
Exp Cell Res; 2020 Jun; 391(1):112004. PubMed ID: 32289284
[TBL] [Abstract][Full Text] [Related]
4. De-ubiquitination of p300 by USP12 Critically Enhances METTL3 Expression and Ang II-induced cardiac hypertrophy.
Lu P; Xu Y; Sheng ZY; Peng XG; Zhang JJ; Wu QH; Wu YQ; Cheng XS; Zhu K
Exp Cell Res; 2021 Sep; 406(1):112761. PubMed ID: 34339675
[TBL] [Abstract][Full Text] [Related]
5. SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy.
Tang X; Chen XF; Wang NY; Wang XM; Liang ST; Zheng W; Lu YB; Zhao X; Hao DL; Zhang ZQ; Zou MH; Liu DP; Chen HZ
Circulation; 2017 Nov; 136(21):2051-2067. PubMed ID: 28947430
[TBL] [Abstract][Full Text] [Related]
6. CSN5 attenuates Ang II-induced cardiac hypertrophy through stabilizing LKB1.
Sheng Z; Xu Y; Li F; Wang S; Huang T; Lu P
Exp Cell Res; 2019 Mar; 376(1):11-17. PubMed ID: 30710502
[TBL] [Abstract][Full Text] [Related]
7. Regulating the stability and localization of CDK inhibitor p27(Kip1) via CSN6-COP1 axis.
Choi HH; Guma S; Fang L; Phan L; Ivan C; Baggerly K; Sood A; Lee MH
Cell Cycle; 2015; 14(14):2265-73. PubMed ID: 25945542
[TBL] [Abstract][Full Text] [Related]
8. A novel circ_0018553 protects against angiotensin-induced cardiac hypertrophy in cardiomyocytes by modulating the miR-4731/SIRT2 signaling pathway.
Zuo H; Li L; Wang X; Chen S; Liao Z; Wei S; Ruan H; Li T; Chen J
Hypertens Res; 2023 Feb; 46(2):421-436. PubMed ID: 36474029
[TBL] [Abstract][Full Text] [Related]
9. The Emerging Role of CSN6 in Biological Behavior and Cancer Progress.
Mao Z; Chen C; Pei DS
Anticancer Agents Med Chem; 2019; 19(10):1198-1204. PubMed ID: 30961513
[TBL] [Abstract][Full Text] [Related]
10. CSN6 controls the proliferation and metastasis of glioblastoma by CHIP-mediated degradation of EGFR.
Hou J; Deng Q; Zhou J; Zou J; Zhang Y; Tan P; Zhang W; Cui H
Oncogene; 2017 Feb; 36(8):1134-1144. PubMed ID: 27546621
[TBL] [Abstract][Full Text] [Related]
11. Klotho inhibits angiotensin II-induced cardiomyocyte hypertrophy through suppression of the AT1R/beta catenin pathway.
Yu L; Meng W; Ding J; Cheng M
Biochem Biophys Res Commun; 2016 Apr; 473(2):455-61. PubMed ID: 26970306
[TBL] [Abstract][Full Text] [Related]
12. CIKS (Act1 or TRAF3IP2) mediates Angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy.
Valente AJ; Clark RA; Siddesha JM; Siebenlist U; Chandrasekar B
J Mol Cell Cardiol; 2012 Jul; 53(1):113-24. PubMed ID: 22575763
[TBL] [Abstract][Full Text] [Related]
13. CSN6, a subunit of the COP9 signalosome, is involved in early response to iron deficiency in Oryza sativa.
Tan S; Liu F; Pan XX; Zang YP; Jin F; Zu WX; Qi XT; Xiao W; Yin LP
Sci Rep; 2016 May; 6():25485. PubMed ID: 27137867
[TBL] [Abstract][Full Text] [Related]
14. Activation of the cardiac proteasome promotes angiotension II-induced hypertrophy by down-regulation of ATRAP.
Li N; Wang HX; Han QY; Li WJ; Zhang YL; Du J; Xia YL; Li HH
J Mol Cell Cardiol; 2015 Feb; 79():303-14. PubMed ID: 25526681
[TBL] [Abstract][Full Text] [Related]
15. CSN6 Promotes the Migration and Invasion of Cervical Cancer Cells by Inhibiting Autophagic Degradation of Cathepsin L.
Mao Z; Sang MM; Chen C; Zhu WT; Gong YS; Pei DS
Int J Biol Sci; 2019; 15(6):1310-1324. PubMed ID: 31223289
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-(1-7) prevents cardiomyocyte pathological remodeling through a nitric oxide/guanosine 3',5'-cyclic monophosphate-dependent pathway.
Gomes ER; Lara AA; Almeida PW; Guimarães D; Resende RR; Campagnole-Santos MJ; Bader M; Santos RA; Guatimosim S
Hypertension; 2010 Jan; 55(1):153-60. PubMed ID: 19996065
[TBL] [Abstract][Full Text] [Related]
17. EndophilinA2 protects against angiotensin II-induced cardiac hypertrophy by inhibiting angiotensin II type 1 receptor trafficking in neonatal rat cardiomyocytes.
Liu Y; Shen HJ; Wang XQ; Liu HQ; Zheng LY; Luo JD
J Cell Biochem; 2018 Nov; 119(10):8290-8303. PubMed ID: 29923351
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-92b-3p suppresses angiotensin II-induced cardiomyocyte hypertrophy via targeting HAND2.
Yu XJ; Huang YQ; Shan ZX; Zhu JN; Hu ZQ; Huang L; Feng YQ; Geng QS
Life Sci; 2019 Sep; 232():116635. PubMed ID: 31283925
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-122 promotes cardiomyocyte hypertrophy via targeting FoxO3.
Song G; Zhu L; Ruan Z; Wang R; Shen Y
Biochem Biophys Res Commun; 2019 Nov; 519(4):682-688. PubMed ID: 31543343
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-Induced Mitogenic Factor Promotes Cardiac Hypertrophy via Calcium-Dependent and Hypoxia-Inducible Factor-1α Mechanisms.
Kumar S; Wang G; Liu W; Ding W; Dong M; Zheng N; Ye H; Liu J
Hypertension; 2018 Aug; 72(2):331-342. PubMed ID: 29891648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
